Shi Xu

610 citations
19 papers · 411 indexed · h-index 11
Topics
Cancer Research and Treatments (6 papers)Amino Acid Enzymes and Metabolism (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)
Journals
SHILAP Revista de lepidopterologíaOncogeneScientific Reports

In The Last Decade

Shi Xu

18 papers receiving 408 citations

Peers

Shi Xu
Comparison fields: 5 of 80
  • Molecular Biology 204
  • Cancer Research 121
  • Oncology 113
  • Biotechnology 95
  • Pulmonary and Respiratory Medicine 50
Replace Jodi M. Coates with:
Jodi M. Coates United States
Guofeng Ma China
Aino Paasinen-Sohns Finland
Brittany Durden United States
Zuzanna Rydzyńska Poland
Sonia Voiculescu United States
Hidenori Miyamoto Japan
Yanhua Yao China
Shannon M. Wilson United States
Shi Xu relative to Jodi M. Coates United States Jodi M. Coates's profile →
Citations per field
00.5×
Jodi M. Coates · 1×
Citations per year

Countries citing papers authored by Shi Xu

Since Specialization
Citations

This map shows the geographic impact of Shi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Xu more than expected).

Fields of papers citing papers by Shi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Xu. The network helps show where Shi Xu may publish in the future.

Co-authorship network of co-authors of Shi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shi Xu. A scholar is included among the top collaborators of Shi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi Xu. Shi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 2
2 2
3 2
4 2
5 0
6 15
7
A Model Using Support Vector Machines Recursive Feature Elimination (SVM-RFE) Algorithm to Classify Whether COPD Patients Have Been Continuously Managed According to GOLD Guidelines
1
8 4
9 89
10 110
11 7
12 16
13 13
14 15
15 32
16 32
17 23
18 15
19 31

About Shi Xu

Shi Xu is a scholar working on Biotechnology, Biochemistry and Cancer Research, having authored 19 papers that have together received 411 indexed citations. Recurring topics across this work include Cancer Research and Treatments (6 papers), Amino Acid Enzymes and Metabolism (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Biotechnology (95 citations), Cancer Research (121 citations) and Biochemistry (49 citations). Shi Xu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Changneng Ke, Po Liu, Xiangmei Wang, Jcm Ho, Sze Kwan Lam, Paul N. Cheng, Yuwen Wang, Dongwei Guo, Lili Yu and Lingyun Xiong. Their work appears in journals such as SHILAP Revista de lepidopterología, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026